ATCT-01 PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG)

Published

Conference Paper

ATCT-01

Full Text

Cited Authors

  • Affronti, ML; Friedman, HS; Desjardins, A; Vlahovic, G; Randazzo, DM; Herndon, JE; McSherry, F; Lipp, ES; Mannerico, A; Massey, W; Miller, E; Iden, D; Peters, KB

Duke Contributors

Published Date

  • November 1, 2015

Published In

Volume / Issue

  • 17 / suppl 5

Start / End Page

  • v1 - v1

Published By

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Digital Object Identifier (DOI)

  • 10.1093/neuonc/nov206.01

Conference Name

  • 20th Annual Scientific Meeting of the Society for Neuro-Oncology

Conference Location

  • San Antonio, TX

Conference Start Date

  • November 19, 2015

Conference End Date

  • November 22, 2015